Finotti P, Piccoli A, Carraro P
Department of Pharmacology, University of Padova, Italy.
Diabetes Res Clin Pract. 1992 Oct;18(1):35-42. doi: 10.1016/0168-8227(92)90053-t.
The aim of the present study was to investigate whether or not alterations of the plasma proteinase-antiproteinase system were present in type 1 (insulin-dependent) diabetic patients and, if so, whether or not they were related to sex, age at onset and duration of the disease as well as to short- and long-term diabetic control. The plasma concentration of trypsin-like activity and two of the most important plasma serine proteinase inhibitors, alpha 1-antitrypsin and alpha 2-macroglobulin, were determined in 95 type 1 diabetic and 67 control subjects. The plasma concentration of alpha 1 antitrypsin was found to be markedly decreased (P < 0.001), whereas plasma alpha 2-macroglobulin and trypsin-like activity were increased in diabetics compared to controls (P = 0.009 and < 0.001, respectively). Sex also influenced the values of both proteinase inhibitors in diabetics, women showing higher values of plasma alpha 1-antitrypsin (P = 0.004) than men. In women, HbA1c was also positively correlated with blood glucose (P < 0.001), daily insulin dosage (P < 0.001), and trypsin-like activity of plasma (P = 0.02). On the contrary, in men, HbA1c appeared to be negatively correlated with plasma alpha 2-macroglobulin (P = 0.02). In addition to sex, age at onset (but not duration) of the disease revealed differences in plasma alpha 1-antitrypsin among diabetics, the lowest mean value of this inhibitor being present in men with age at onset below 15 years, who also showed a significant negative correlation between this inhibitor and HbA1c (P = 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)
本研究的目的是调查1型(胰岛素依赖型)糖尿病患者血浆蛋白酶-抗蛋白酶系统是否存在改变,如果存在改变,这些改变是否与性别、发病年龄、病程以及短期和长期糖尿病控制情况有关。测定了95例1型糖尿病患者和67例对照者血浆中类胰蛋白酶活性以及两种最重要的血浆丝氨酸蛋白酶抑制剂α1-抗胰蛋白酶和α2-巨球蛋白的浓度。结果发现,糖尿病患者血浆α1-抗胰蛋白酶浓度显著降低(P<0.001),而血浆α2-巨球蛋白和类胰蛋白酶活性与对照组相比有所升高(分别为P=0.009和P<0.001)。性别也影响糖尿病患者体内这两种蛋白酶抑制剂的值,女性血浆α1-抗胰蛋白酶的值高于男性(P=0.004)。在女性中,糖化血红蛋白(HbA1c)还与血糖(P<0.001)、每日胰岛素剂量(P<0.001)以及血浆类胰蛋白酶活性(P=0.02)呈正相关。相反,在男性中,HbA1c似乎与血浆α2-巨球蛋白呈负相关(P=0.02)。除性别外,糖尿病患者发病年龄(而非病程)不同,血浆α1-抗胰蛋白酶也存在差异,发病年龄低于15岁的男性该抑制剂的平均水平最低,且该抑制剂与HbA1c之间也存在显著负相关(P=0.01)。(摘要截选至250词)